PEAK6 Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,018
Closed -$496K 5487
2022
Q3
$496K Buy
2,018
+867
+75% +$234K ﹤0.01% 2887
2022
Q2
$285K Buy
+1,151
New +$311K ﹤0.01% 4421
2022
Q1
Sell
-1,715
Closed -$528K 6167
2021
Q4
$616K Sell
1,715
-6,527
-79% -$2.21M ﹤0.01% 3038
2021
Q3
$2.68M Buy
+8,242
New +$2.79M 0.01% 1678
2021
Q2
Sell
-466
Closed -$143K 6005
2021
Q1
$149K Buy
+466
New +$149K ﹤0.01% 4107
2020
Q2
Sell
-616
Closed -$124K 4966
2020
Q1
$89K Sell
616
-24,746
-98% -$4.11M ﹤0.01% 3358
2019
Q4
$4.33M Sell
25,362
-24,271
-49% -$4.5M 0.02% 688
2019
Q3
$8.83M Buy
49,633
+30,338
+157% +$6.56M 0.06% 406
2019
Q2
$5.03M Sell
19,295
-6,226
-24% -$1.65M 0.03% 688
2019
Q1
$7.29M Buy
25,521
+17,868
+233% +$5.94M 0.04% 510
2018
Q4
$2.49M Buy
+7,653
New +$2.66M 0.02% 1081

Other funds holding ABMD

PEAK6 Investments's ABMD Position: Q4 2022 in Review

PEAK6 Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,018 shares — an estimated $496K sold.

PEAK6 Investments first reported a position in ABMD in Q4 2018 and held it in 11 quarters. The position peaked at $8.83M in Q3 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • PEAK6 Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • PEAK6 Investments sold 2,018 Abiomed Inc shares in Q4 2022, an estimated $496K.
  • PEAK6 Investments first reported a position in Abiomed Inc in Q4 2018 and held it in 11 quarters.
  • PEAK6 Investments's Abiomed Inc position peaked at $8.83M in Q3 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.